Forte Biosciences Inc. (NASDAQ: FBRX)
$0.56
+0.0020 ( +0.36% ) 22.1K
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, and alopecia areata (AA).
Market Data
Open
$0.56
Previous close
$0.56
Volume
22.1K
Market cap
$21.14M
Day range
$0.57 - $0.59
52 week range
$0.38 - $1.03
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Jul 03, 2024 |
4 | Insider transactions | 1 | Jul 03, 2024 |
8-k | 8K-related | 16 | Jun 14, 2024 |
10-q | Quarterly Reports | 57 | May 13, 2024 |
8-k | 8K-related | 48 | May 13, 2024 |
10-k/a | Quarterly Reports | 17 | Apr 29, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Apr 02, 2024 |
4 | Insider transactions | 1 | Mar 25, 2024 |
4 | Insider transactions | 1 | Mar 25, 2024 |